NSRX – nasus pharma ltd. ordinary shares (US:NASDAQ)
Stock Stats
News
Nasus Pharma Announces Positive Interim Results from Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder
Nasus Pharma CEO Issues 2025 Letter to Shareholders
Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin as Executive Vice President and Chief Financial Officer
Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed [Yahoo! Finance]
Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed
Form 6-K Nasus Pharma Ltd For: Jan 29
Form 6-K Nasus Pharma Ltd For: Jan 20
Form 6-K Nasus Pharma Ltd For: Jun 30
Form 6-K Nasus Pharma Ltd For: Dec 22
Form 6-K Nasus Pharma Ltd For: Nov 20
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.